A family of triazine dendrimers, differing in their core flexibility, generation number, and surface functionality, was prepared and evaluated for its ability to accomplish RNAi. The dendriplexes were analyzed with respect to their physicochemical and biological properties, including condensation of siRNA, complex size, surface charge, cellular uptake and subcellular distribution, their potential for reporter gene knockdown in HeLa/Luc cells, and ultimately their stability, biodistribution, pharmacokinetics and intracellular uptake in mice after intravenous (iv) administration. The structure of the backbone was found to significantly influence siRNA transfection efficiency, with rigid, second generation dendrimers displaying higher gene knockdown than the flexible analogues while maintaining less off-target effects than Lipofectamine. Additionally, among the rigid, second generation dendrimers, those with either arginine-like exteriors or peripheries containing hydrophobic functionalities mediated the most effective gene knockdown, thus showing that dendrimer surface groups also affect transfection efficiency. Moreover, these two most effective dendriplexes were stable in circulation upon intravenous administration and showed passive targeting to the lung. Both dendriplex formulations were taken up into the alveolar epithelium, making them promising candidates for RNAi in the lung. The ability to correlate the effects of triazine dendrimer core scaffolds, generation number, and surface functionality with siRNA transfection efficiency yields valuable information for further modifying this nonviral delivery system and stresses the importance of only loosely correlating effective gene delivery vectors with siRNA transfection agents.
A family of triazine dendrimers, differing in their core flexibility, genen>an class="Species">ration number, and surface functionality, was prepared and evaluated for its ability to accomplish RNAi. The dendriplexes were analyzed with respect to their physicochemical and biological properties, including condensation of siRNA, complex size, surface charge, cellular uptake and subcellular distribution, their potential for reporter gene knockdown in HeLa/Luc cells, and ultimately their stability, biodistribution, pharmacokinetics and intracellular uptake in mice after intravenous (iv) administration. The structure of the backbone was found to significantly influence siRNA transfection efficiency, with rigid, second generation dendrimers displaying higher gene knockdown than the flexible analogues while maintaining less off-target effects than Lipofectamine. Additionally, among the rigid, second generation dendrimers, those with either arginine-like exteriors or peripheries containing hydrophobic functionalities mediated the most effective gene knockdown, thus showing that dendrimer surface groups also affect transfection efficiency. Moreover, these two most effective dendriplexes were stable in circulation upon intravenous administration and showed passive targeting to the lung. Both dendriplex formulations were taken up into the alveolar epithelium, making them promising candidates for RNAi in the lung. The ability to correlate the effects of triazine dendrimer core scaffolds, generation number, and surface functionality with siRNA transfection efficiency yields valuable information for further modifying this nonviral delivery system and stresses the importance of only loosely correlating effective gene delivery vectors with siRNA transfection agents.
Authors: Giovanni M Pavan; Meredith A Mintzer; Eric E Simanek; Olivia M Merkel; Thomas Kissel; Andrea Danani Journal: Biomacromolecules Date: 2010-03-08 Impact factor: 6.988
Authors: Rafael Gras; Luis Almonacid; Paula Ortega; Maria J Serramia; Rafael Gomez; F Javier de la Mata; Luis A Lopez-Fernandez; M Angeles Muñoz-Fernandez Journal: Pharm Res Date: 2008-11-25 Impact factor: 4.200
Authors: Mahesh L Patil; Min Zhang; Oleh Taratula; Olga B Garbuzenko; Huixin He; Tamara Minko Journal: Biomacromolecules Date: 2009-02-09 Impact factor: 6.988
Authors: Olivia M Merkel; Mengyao Zheng; Meredith A Mintzer; Giovanni M Pavan; Damiano Librizzi; Marek Maly; Helmut Höffken; Andrea Danani; Eric E Simanek; Thomas Kissel Journal: J Control Release Date: 2011-02-20 Impact factor: 9.776
Authors: Yin Tang; Yang-Bing Li; Bo Wang; Ri-Yuan Lin; Mallory van Dongen; Danielle M Zurcher; Xiao-Yan Gu; Mark M Banaszak Holl; George Liu; Rong Qi Journal: Mol Pharm Date: 2012-05-14 Impact factor: 4.939
Authors: Mengyao Zheng; Giovanni M Pavan; Manuel Neeb; Andreas K Schaper; Andrea Danani; Gerhard Klebe; Olivia M Merkel; Thomas Kissel Journal: ACS Nano Date: 2012-10-09 Impact factor: 15.881
Authors: Zhihang Chen; Marie-France Penet; Sridhar Nimmagadda; Cong Li; Sangeeta R Banerjee; Paul T Winnard; Dmitri Artemov; Kristine Glunde; Martin G Pomper; Zaver M Bhujwalla Journal: ACS Nano Date: 2012-08-09 Impact factor: 15.881